Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ACXP - Acurx Pharmaceuticals Inc.'s (ACXP) CEO David Luci On Q1 2022 Results - Earnings Call Transcript

ACXP - Acurx Pharmaceuticals Inc.'s (ACXP) CEO David Luci On Q1 2022 Results - Earnings Call Transcript

Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals, Inc. (ACXP) Q1 2022 Earnings Conference Call May 11, 2022 8:30 A.M. ET Company Participants Rob Shawah - Chief Financial Officer David Luci - President and Chief Executive Officer Conference Call Participants Chad Yahn - Maxim Group Joanne Lee - Maxim Group Presentation Operator Greetings and welcome to the Acurx Pharmaceuticals, Inc. First Quarter 2022 Results and Business Update. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, the conference is being recorded. I would now like to turn the conference over to your host, Rob Shawah, Chief Financial Officer. Please go ahead. Rob Shawah Thank you. Good morning, and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the first quarter of 2022. This press release is available on our website at acurxpharmaceuticals.com. Joining me today is Dave Luci, President and Chief

For further details see:

Acurx Pharmaceuticals, Inc.'s (ACXP) CEO David Luci On Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Acurx Pharmaceuticals Inc.
Stock Symbol: ACXP
Market: NASDAQ
Website: acurxpharma.com
Menu
ACXP ACXP Quote ACXP Short ACXP News ACXP Articles ACXP Message Board
Get ACXP Alerts

News, Short Squeeze, Breakout and More Instantly...